densitas densityai

by Densitas  · Based in Canada → — Transforming the Mammography Enterprise with AI Solutions
Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Densitas densityai™ is a deep learning algorithm that provides automated, standardized, and reproducible breast density assessments from mammograms. It is a core component of the broader intelliMammo™ platform by Densitas Inc., which offers comprehensive AI solutions for breast cancer screening.

The tool uniquely utilizes two distinct deep learning models to decouple breast density assessment into quantitative percent mammographic density (0%-100%) and qualitative descriptive categories (A, B, C, D), aligning with both the ACR BI-RADS® 4th and 5th Edition density scales. By eliminating the subjectivity and lack of reliability associated with visual assessment, densityai™ establishes standardization across entire health systems, supporting compliance with federal and regional breast density notification laws.

Densitas densityai™ seamlessly integrates into existing reporting and PACS workflows, boosting efficiency and facilitating retrospective analyses. It processes routinely archived ‘for presentation’ images and generates results that are available on-demand at the point of care for radiological technologists and radiologists, and retrospectively for clinic and health system administrators through an advanced analytics platform.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated and standardized breast density assessments
  • Aligns with ACR BI-RADSu00ae Atlas 4th and 5th Edition density scales
  • Eliminates subjectivity and improves reproducibility of breast density assessment
  • Supports compliance with federal and regional breast density notification laws
  • Integrates into existing reporting and PACS workflows
  • Identifies higher-risk women for supplemental screening
  • Utilizes deep learning models for analysis
  • Processes routinely archived 'for presentation' mammograms
  • Generates Secondary Capture (SC) and Structured Report (SR) objects
  • Provides quantitative percent mammographic density and qualitative descriptive categories

Use Cases

  • Standardized breast density classification at point-of-care
  • Ensuring compliance with breast density reporting requirements
  • Informing referral pathways for supplemental imaging
  • Risk stratification of patients for tailored follow-up screening protocols
  • Improving workflow efficiency and reducing unnecessary callbacks
  • Supporting breast cancer screening trials and research

What Physicians Need to Know

Key Capabilities
densitas densityai™ offers fully automated, standardized, and reproducible breast density assessments from standard DICOM clinical use mammograms. It utilizes two distinct deep learning models to provide both quantitative (0%-100%) and qualitative (ACR BI-RADS 4th and 5th Ed. density scales A, B, C, D) breast density assessments. The software can process approximately 600 cases per hour. It is part of the broader intelliMammo™ platform, which also includes densitas qualityai™ for image quality assessment and densitas riskai™ for breast cancer risk assessment. The intelliMammo® platform also includes intelliMammo® Copilot, a GPT AI add-on that provides expert feedback on mammography positioning techniques and answers complex questions related to quality improvement and operational workflows.
Clinical Utility
The solution aids interpreting physicians in assessing breast tissue composition by providing an ACR BI-RADS Atlas 5th Edition breast density category. It helps eliminate subjectivity and lack of reproducibility associated with visual assessment, establishing standardization across health systems. Density assessments can be incorporated into risk models to evaluate patient-specific breast cancer risk and support risk-stratification for tailored follow-up screening protocols. It also supports compliance with federal and regional breast density notification laws. The platform aims to automate routine, time-consuming, subjective, and fatiguing tasks for radiologists, allowing them to focus on more challenging interpretive tasks. It can analyze routinely archived mammograms for retrospective comparisons. The intelliMammo® platform also helps improve mammography quality, optimize operational efficiencies, reduce clinical care team burnout, simplify compliance with MQSA EQUIP, and inform tailored technologist training protocols.
Integration Options
densitas densityai™ is designed for seamless integration into existing reporting and PACS workflows. It can connect with systems like PACS, DICOM, and Epic. It is available on the Nuance AI Marketplace, making it accessible to a large network of healthcare facilities. Integrations include Nuance PowerScribe One and PowerScribe 360 Reporting, Ikonopedia structured breast reporting and tracking software, TeraRecon's AI interoperability platform EnvoyAI, Blackford Platform, and Kailo Medical's KailoHub, which transfers density measurements directly into radiologist reports. The solution generates a Secondary Capture (SC) report for clinical viewing and a Structured Report (SR) object by default.
Compliance Status
densitas densityai™ is FDA-cleared (510(k) cleared, Class II). It supports compliance with FDA Density Reporting Requirements, FDA MQSA EQUIP, and aligns with ACR BI-RADS Atlas Breast Density Scales. It is also available in Canada, Europe, the UK, and Australia for select scanners and models. The intelliMammo® platform helps minimize the administrative burden of NHSBSP compliance in the UK.
Pricing Model
Densitas does not publish its pricing model. Interested parties are advised to contact the company directly for current terms. No free plan or trial was found in the reviewed sources.
User Experience
The solution aims to streamline workflows and reduce radiologist dictation time by automatically populating breast density results into reporting systems. It provides on-demand actionable insights at the point of care for radiological technologists and radiologists. The intelliMammo® Copilot, a GPT AI add-on, is designed to provide expert feedback in real-time, offer tailored mammography quality training recommendations, and clarify complex information for efficient and effective mammography services, thereby mitigating burnout.
Implementation Complexity
The system is designed to process routinely archived mammograms, simplifying clinical deployments and making it cost-effective. Well-integrated, Densitas aims to become an integral part of breast density AI workflows rather than a separate application. It processes standard DICOM clinical use images.
Evidence Base
The densitas densityai™ solution is specifically designed to align with how the visual cortex processes images when radiologists visualize mammograms, and rapidly generates reproducible and standardized breast density assessments that line up with the ACR BI-RADS 5th ed. Atlas guidance. Internal verification and validation testing confirm that product specifications have been met. The software's results were compared to a consensus assessment of four expert radiologists' independent readings on a large dataset, showing strong agreement. Densitas intelliMammo® AI algorithms were utilized in a multicenter study involving over 126,000 mammograms to evaluate mammography positioning quality.
Physician Tip

When utilizing densitas densityai™, leverage its automated breast density assessments to standardize reporting and ensure compliance with regulatory guidelines like ACR BI-RADS 5th Edition. Integrate the results into patient risk models to personalize screening protocols and identify high-risk individuals for supplemental screening. The system's ability to process historical mammograms can be valuable for retrospective analysis and tracking changes in breast density over time. Utilize the intelliMammo® platform's qualityai™ and intelliMammo® Copilot features to monitor and improve mammography image quality and technologist performance, reducing the need for costly technical recalls and enhancing overall departmental efficiency. Remember that densitas densityai™ provides adjunctive information and is not a diagnostic aid; clinical decisions should always be made by a qualified physician.

densitas densityai™ is designed for deep integration into existing radiology workflows. It connects with PACS, DICOM, and EHR systems like Epic. Key integrations include the Nuance AI Marketplace (PowerScribe One and PowerScribe 360 Reporting), Ikonopedia, TeraRecon's EnvoyAI, Blackford Platform, and Kailo Medical's KailoHub. These integrations facilitate the automatic transfer of breast density measurements directly into radiologist reports, streamlining the reporting process and ensuring standardized data capture. Before connecting, decide which system will be the source of truth for each data type and test with a small sample. Keep permissions tight to ensure the agent only accesses necessary data.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentHybrid (on-premise integration with PACS/reporting systems, cloud-based analytics platform)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

What the Web Says

Densitas densityai is an FDA-cleared AI-powered software designed for digital mammography to provide automated, standardized, and reproducible breast density assessments. It aims to eliminate subjectivity in visual assessments and align with ACR BI-RADS classifications, supporting physicians in identifying women who may benefit from supplemental screening.

Overall: Positive

Strengths

  • Automated, standardized, and reproducible breast density assessments.
  • Aligns with ACR BI-RADS 4th and 5th edition classifications.
  • FDA-cleared.
  • Integrates with existing reporting and PACS workflows.
  • Supports compliance with federal and regional breast density notification laws.
  • Helps identify women with dense breasts who may benefit from supplemental screening.

Limitations

  • Pricing is not publicly available.
  • No free plan or trial was found.
  • The vendor website was unreachable during research for one source.
  • Commercial systems like DensityAI can be expensive and require high-performance computing infrastructure, potentially limiting adoption in some healthcare environments.

Based on reviews from: capterra.com, topify.ai, petriashvili.com, remio.ai, densitylabs.io, tradingview.com, saaskart.co, densitashealth.co.uk, itnonline.com, blackfordanalysis.com, prnewswire.com, vporoom.com, nih.gov, innolitics.com, reddit.com, engineering.com, datacenterdynamics.com, stocktitan.net, timothysykes.com, g2.com, myquoteiq.com, g2vp.com, rfp.wiki

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate densitas densityai

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

radiologybusiness.com
The Densitas densityai software is compatible with FFDM and digital breast tomosynthesis systems and provides an ACR BI-RADS Atlas 5th Edition breast density category to aid interpreting physicians in the assessment of breast tissue composition. It was first cleared in February 2018.
Densitas densityai software, compatible with FFDM and digital breast tomosynthesis systems, provides an ACR BI-RADS Atlas 5th Edition breast density category to assist physicians in assessing breast tissue composition. The software received its initial clearance in February 2018.
2024-08
kjfp.or.kr
Application of Artificial Intelligence in Breast Imaging: Current Landscape and Prospects.
This article discusses the current landscape and future prospects of artificial intelligence in breast imaging, highlighting how AI, including Densitas densityai, is being used for breast density assessment and lesion characterization.
2023-12
nih.gov
Densitas Densityai, Densitas, Inc. The BI-RADS breast density category using mammography, K192973, 2020.
Densitas Densityai, developed by Densitas, Inc., received FDA clearance (K192973) in 2020 for providing BI-RADS breast density categorization using mammography.
2020-XX

Videos

Product demos, reviews, and walkthroughs for densitas densityai.

View all on YouTube

Frequently Asked Questions

Densitas densityAI is a software application that provides automated, standardized, and reproducible breast density assessments from mammograms, aligning with ACR BI-RADS Atlas 5th Edition breast density categories. This assessment aids interpreting physicians in evaluating breast tissue composition, which is crucial because dense breasts can mask cancers and are an independent risk factor for breast cancer. The density assessments can also be incorporated into risk models to evaluate patient-specific breast cancer risk.
Densitas densityAI is FDA-cleared and available on the Nuance AI Marketplace. The software helps facilities streamline compliance with key MQSA EQUIP and adherence to ACR accreditation requirements, quality assurance, and oversight tasks. It also supports compliance with federal and regional breast density notification laws, encouraging discussions between women and their physicians about additional screening.
Alternatives to Densitas densityAI include Lunit for breast screening AI, ScreenPoint Medical for mammography AI, and Therapixel for breast cancer detection. Other commercial tools like PowerLook Density Assessment (iCAD) also provide breast density assessments. Additionally, iCAD's ProFound Breast Health Suite offers solutions for cancer detection, density assessment, and personalized risk evaluation.
While Densitas densityAI provides automated breast density calculation, it is important to note that it produces adjunctive information and is not a diagnostic aid. Although AI-based density assessments show good agreement with radiologists, the subjective visual assessments of breast density by radiologists are known to have inter- and intra-observer variability.
Densitas does not publicly disclose its pricing for densityAI. Interested parties are advised to contact the company directly for current terms. Based on available information, there is no free plan or trial for Densitas densityAI.

Related Tools

SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Paid
CerviCARE AI
NTL Healthcare
OB/GYN AI
CerviCARE AI is an AI-powered cervical cancer screening system that analyzes smartphone images of the cervix to predict findings, aiming for early detection.
Lumonus AI
Lumonus
Clinical Decision Support & Reference
Lumonus AI is an AI-powered software that assists healthcare providers with prescriptions, dosing, and treatment for cancer patients, with a module (Sigma) that suggests treatment protocols based on prior plans for similar patients.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.
Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.

See all Oncology AI tools →

More from Densitas

DM-Density
Densitas
Oncology AI
Densitas' DM-Density, now densitas densityai™, is an FDA-cleared AI software for automated and standardized breast density assessment from digital mammograms, aligning with ACR BI-RADS® Atlas 5th Edition.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.